title: Intermittent dystonia in Hartnup disease.
abstract: A 6-month-old girl developed intermittent dystonic posture of the legs and eczematous dermatitis without ataxia. Qualitative and quantitative urine amino acid testing confirmed the diagnosis of Hartnup disease. Cranial computed tomography, electroencephalogram, electromyogram/nerve conduction study, posterior tibial somatosensory evoked potentials, 24-hour electroencephalographic telemetry, and metrizamide myelogram were normal. Spinal fluid hydroxy-indoleacetic acid concentration was less than or equal to 2 S.D. of normal; oral tryptophan loading (70 mg/kg) resulted in a two-fold rise in cerebrospinal fluid 5-hydroxy-indoleacetic acid concentration. Tryptophan administered alone or with nicotinic acid failed to improve the dystonia; however, trihexyphenidyl (1-2 mg/kg/day) dramatically improved it. Hartnup disease should be considered in children with unexplained dystonia.
authors.affiliation: Division of Pediatric Neurology, Boston Floating Hospital, Massachusetts.
authors.forename: B T
authors.initials: BT
authors.lastname: Darras
authors.forename: M G
authors.initials: MG
authors.lastname: Ampola
authors.forename: W H
authors.initials: WH
authors.lastname: Dietz
authors.forename: H E
authors.initials: HE
authors.lastname: Gilmore
mesh_terms: D001923:Brain Chemistry / Q000187:drug effects; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D005260:Female; D006250:Hartnup Disease / Q000150:complications*; D006801:Humans; D007223:Infant; D009525:Niacin / Q000627:therapeutic use; D014282:Trihexyphenidyl / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use
chemical_list: D009525:Niacin; D014282:Trihexyphenidyl; D014364:Tryptophan